Bank of New York Mellon
NUVB icon

Bank of New York Mellon’s Nuvation Bio NUVB Stock Holding History

Bank of New York Mellon’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Sell
669,687
-13,810
-2% -$67.5K ﹤0.01% 2601
2026
Q1 		$2.93M Sell
683,497
-3,731
-0.5% -$20.8K ﹤0.01% 2611
2025
Q4 		$6.16M Sell
687,228
-40,666
-6% -$252K ﹤0.01% 2206
2025
Q3 		$2.69M Buy
727,894
+59,080
+9% +$161K ﹤0.01% 2648
2025
Q2 		$1.3M Buy
668,814
+149,947
+29% +$312K ﹤0.01% 2973
2025
Q1 		$913K Buy
518,867
+292
+0.1% +$665 ﹤0.01% 3119
2024
Q4 		$1.38M Buy
518,575
+14,203
+3% +$36.6K ﹤0.01% 2949
2024
Q3 		$1.16M Sell
504,372
-122,533
-20% -$374K ﹤0.01% 3061
2024
Q2 		$1.83M Buy
626,905
+157,511
+34% +$481K ﹤0.01% 2836
2024
Q1 		$1.71M Sell
469,394
-48,710
-9% -$93.5K ﹤0.01% 2847
2023
Q4 		$782K Buy
518,104
+1,500
+0.3% +$1.93K ﹤0.01% 3318
2023
Q3 		$692K Buy
516,604
+217
+0% +$361 ﹤0.01% 3380
2023
Q2 		$929K Buy
516,387
+61,228
+13% +$104K ﹤0.01% 3234
2023
Q1 		$756K Sell
455,159
-14,201
-3% -$28.8K ﹤0.01% 3265
2022
Q4 		$901K Buy
469,360
+28,837
+7% +$58.3K ﹤0.01% 3243
2022
Q3 		$987K Buy
440,523
+40,055
+10% +$114K ﹤0.01% 3208
2022
Q2 		$1.3M Sell
400,468
-90,903
-18% -$396K ﹤0.01% 3073
2022
Q1 		$2.58M Buy
491,371
+503
+0.1% +$2.83K ﹤0.01% 2796
2021
Q4 		$4.17M Buy
490,868
+207,498
+73% +$1.91M ﹤0.01% 2558
2021
Q3 		$2.82M Buy
283,370
+134,797
+91% +$1.22M ﹤0.01% 2798
2021
Q2 		$1.38M Buy
148,573
+124,453
+516% +$1.42M ﹤0.01% 3225
2021
Q1 		$252K Buy
+24,120
New +$270K ﹤0.01% 3974

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon's NUVB Position: Q2 2026 in Review

Bank of New York Mellon reduced its Nuvation Bio (NUVB) stake by 2% in Q2 2026, selling an estimated $67.5K and leaving 669,687 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Bank of New York Mellon first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.16M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Bank of New York Mellon held 669,687 shares of Nuvation Bio worth $3.8M as of Q2 2026.
  • Bank of New York Mellon sold 13,810 Nuvation Bio shares in Q2 2026, an estimated $67.5K.
  • Nuvation Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2601 holding.
  • Bank of New York Mellon first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
  • Bank of New York Mellon's Nuvation Bio position peaked at $6.16M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.